Cargando…
In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
Breast cancer is the most frequently diagnosed cancer in women and the second most common cancer overall, with nearly [Formula: see text] million new cases worldwide every year. Breast cancer patients need accurate tools for early diagnosis and to improve treatment. Biomarkers are increasingly used...
Autores principales: | Mazo, Claudia, Orue-Etxebarria, Estibaliz, Zabalza, Ignacio, Vivanco, Maria d. M., Kypta, Robert M., Beristain, Andoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316458/ https://www.ncbi.nlm.nih.gov/pubmed/30558303 http://dx.doi.org/10.3390/cancers10120517 |
Ejemplares similares
-
Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
por: Gorroño-Etxebarria, Irantzu, et al.
Publicado: (2019) -
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1
por: Al Shareef, Zainab, et al.
Publicado: (2018) -
Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014) -
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
por: Domenici, Giacomo, et al.
Publicado: (2019) -
Comparison of Genomic Profiling Data with Clinical Parameters: Implications for Breast Cancer Prognosis
por: López-Ruiz, José A., et al.
Publicado: (2022)